047 Pro-dysfunction and weak anti-cancer tumor infiltrating lymphocytes associated with more aggressive BCC subtype

نویسندگان

چکیده

Background: Immune response is key in defense against basal cell carcinoma (BCC). We aim to better define the immune tumor microenvironment this cancer. Methods: CD8+ infiltrating lymphocytes (TILs) obtained from fresh BCC specimens nodular subtype (“nBCC”, n=6) versus infiltrative (“iBCC”, were subject single-cell RNA profiling. Data analyzed using iCellR. Results: TILs clustered based on gene expression as follows: cytotoxic (GZMA, GZMB, IFN-γ, PRF1); naïve (CCR7, LEF1, TCF7, IL7R, OX40); exhausted (BTLA, CTLA4, PDCD1, TIM3, LAG3, STAT3, 4-1BB); and regulatory (FOXP3, additional subtypes observed for naïve, exhausted, T cells. A significantly greater percentage of lesser iBCC compared nBCC. Further analysis revealed a unique, pro-tumor-controlling nBCC highly suppressive iBCC; moreover, exclusively low activity subtype. Additionally, all was not different across subtype; however, there proportion progenitor terminally Conclusion: Two proportions pro-tumor controlling one lower identified iBCC, possibly contributing relative aggressiveness these tumors. more tended cluster phenotype that may be responsive checkpoint blockade therapy.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

FOXP3 expression in tumor cells and tumor-infiltrating lymphocytes is associated with breast cancer prognosis

The forkhead box protein 3 (FOXP3) transcription factor is highly expressed in tumor cells as well as in regulatory T cells (Tregs). It plays a tumor-enhancing role in Tregs and suppresses carcinogenesis as a potent repressor of several oncogenes. The clinical prognostic value of FOXP3 expression has not yet been elucidated. In this study, immunohistochemistry was used to investigate the progno...

متن کامل

Tumor-infiltrating lymphocytes in breast cancer

We have prospectively validated in an independent clinical cohort the finding that elevated amounts of tumor-infiltrating lymphocytes in breast carcinoma tissues predict the response of patients to neoadjuvant chemotherapy. These results suggest that a robust tumor infiltration by T and B cells is a promising biomarker to define patients who might benefit from neoadjuvant chemotherapy.

متن کامل

Tumor-infiltrating lymphocytes predict prognosis of breast cancer patients treated with anti-Her-2 therapy

PURPOSE Infiltration of tumor associated lymphocytes and count of its different phenotypes are potentially new independent predictor of prognosis in breast cancer. However, research related to it is less reported in breast cancer patients treated with anti-Her-2 therapy. Thus, we evaluated the relationship between survival and tumor infiltrating lymphocytes including its different phenotypes in...

متن کامل

Tumor infiltrating leukocyte density is independent of tumor grade and molecular subtype in aggressive breast cancer of Western Kenya

BACKGROUND Tumors commonly are infiltrated by leukocytes, or tumor infiltrating leukocytes (TILs). It remains unclear, however, if the density and type of individual TILs has a direct or simply correlative role in promoting poor prognosis in breast cancer patients. Breast cancer in Kenyan women is aggressive with presentation at a young age, with advanced grade (grade III), large tumor size (>2...

متن کامل

Tumor Infiltrating Lymphocytes

9 Abstract 10 11 Tumor infiltrating lymphocytes (TILs) have been recognized in various 12 cancers and may reflect a host immune response to malignant cells. TILs 13 are a heterogeneous population of various types of mononuclear cells, 14 including CD8 or CD4 + T cells and their subsets, B cells, myeloid 15 derived suppressor cells (MDSC), macrophages, and other cells. Immuno16 suppressive facto...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Journal of Investigative Dermatology

سال: 2022

ISSN: ['1523-1747', '0022-202X']

DOI: https://doi.org/10.1016/j.jid.2022.05.101